Stage II Gastric Cancer Terminated Phase Trials for Motexafin lutetium (DB05296)

Also known as: Malignant Neoplasm of Stomach Stage II / Gastric cancer stage II / Gastric malignancy stage II / Stomach cancer stage II

IndicationStatusPhase
DBCOND0030354 (Stage II Gastric Cancer)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00087191EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerDiagnostic